China Universal Asset Management »

Sensei Biotherapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Sensei Biotherapeutics (FTH) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $90k 3.6k 25.00

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Micron Technology Common Stock (MU)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Advanced Micro Devices Common Stock (AMD)
Broadcom Common Stock (AVGO)
Intel Corp Common Stock (INTC)
Meta Platforms Inc-class A Common Stock (META)
Applied Materials Common Stock (AMAT)
Alphabet Inc-cl C Common Stock (GOOG)
Lam Research Corp Common Stock (LRCX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)

View all positions for China Universal Asset Management

Top funds holding Sensei Biotherapeutics

Suvretta Capital Management
venBio Select Advisor
Baker Bros. Advisors
Balyasny Asset Management
Cormorant Asset Management
RA Capital Management
Vivo Capital
Fairmount Funds Management
Logos Global Management
Caligan Partners
Trails Edge Capital Partners
Franklin Resources
Octagon Capital Advisors
ADAR1 Capital Management
Marshall Wace

View all funds holding Sensei Biotherapeutics